Oorsprong van het eerstegraads netwerk van Sylvain Carlioz
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
Stimunity SAS
 Stimunity SAS BiotechnologyHealth Technology Stimunity SAS provides biotechnology services. The company is based in Paris, France. The French company was founded in 2016 by Sylvain Carlioz, Nicolas Manel. Sylvain Carlioz has been the CEO since 2016.
2
| Holding Company | Biotechnology | 2 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Sylvain Carlioz via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ENZO BIOCHEM, INC. | Biotechnology | Director/Board Member | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| PORTAGE BIOTECH INC. | Biotechnology | Chief Executive Officer | |
| INTENSITY THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| Albert Einstein College of Medicine, Inc. | College/University | Doctorate Degree | |
| SORRENTO THERAPEUTICS, INC. | Biotechnology | Corporate Officer/Principal | |
Bristol-Myers Squibb Canada Co.
 Bristol-Myers Squibb Canada Co. Pharmaceuticals: MajorHealth Technology Bristol-Myers Squibb Canada Co. designs, develops and wholesales pharmaceutical products. The company is headquartered in Halifax, Canada. | Pharmaceuticals: Major | Chief Operating Officer | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin | |
SalvaRx Ltd.
 SalvaRx Ltd. BiotechnologyHealth Technology SalvaRx Ltd. develops and provides treatment in the field of cancer immunology. The company is headquartered in London, the United Kingdom. | Biotechnology | Chief Executive Officer | |
iOX Therapeutics Ltd.
 iOX Therapeutics Ltd. BiotechnologyHealth Technology iOX Therapeutics Ltd. provides cancer therapeutics services. The company was founded by Vincenzo Cerundolo in February 2015 and is headquartered in London, the United Kingdom. | Biotechnology | Director/Board Member | |
| SALVARX GROUP PLC | Biotechnology | Founder |
Statistieken
Internationaal
| Verenigde Staten | 9 |
| Verenigd Koninkrijk | 5 |
| Canada | 2 |
Sectoraal
| Health Technology | 11 |
| Consumer Services | 3 |
| Finance | 2 |
| Commercial Services | 2 |
Operationeel
| Director/Board Member | 6 |
| Chief Executive Officer | 3 |
| Corporate Officer/Principal | 2 |
| Founder | 2 |
| Chairman | 2 |
Sterkste connecties
| Insiders | |
|---|---|
| Ian Walters | 15 |
| Nicolas Manel | 1 |
- Beurs
- Insiders
- Sylvain Carlioz
- Bedrijfsconnecties
